Hector DeLuca

From Wikipedia, the free encyclopedia
Jump to: navigation, search

Hector F. DeLuca is a University of Wisconsin–Madison professor and former chairman of the university's biochemistry department.[1] DeLuca is well known for his research in involving Vitamin D, from which several pharmaceutical drugs are derived.[2][3] He was elected to the United States National Academy of Sciences in 1979.[4]

DeLuca has trained almost 160 graduate students and has more than 150 patents to his name. Licensing of his technology, through the Wisconsin Alumni Research Foundation, has generated tens of millions of dollars in revenue for the university.[5]

In addition, DeLuca is president of Deltanoid Pharmaceuticals, a biotechnology company founded on technology he developed.[6]

He was awarded The Bolton S. Corson Medal in 1985.[citation needed] Three buildings on the Wisconsin campus, including the DeLuca Biochemistry Building, were named in his honor.

References[edit]

  1. ^ Faculty page for Hector DeLuca
  2. ^ Holick MF, Schnoes HK, DeLuca HF (April 1971). "Identification of 1,25-dihydroxycholecalciferol, a form of vitamin D3 metabolically active in the intestine". Proc Natl Acad Sci U S A 68 (4): 803–4. doi:10.1073/pnas.68.4.803. PMC 389047. PMID 4323790. 
  3. ^ Kresge N, Simoni RD, Hill RL (December 15, 2006). "A half-century of vitamin D: the work of Hector F. DeLuca". The Journal of Biological Chemistry 281 (50): e41. 
  4. ^ "Hector DeLuca". Wisconsin Academy of Sciences, Arts & Letters. Retrieved 4 May 2012. 
  5. ^ Karen Rivedal (12 February 2005). "UW star scientist gives up position Hector DeLuca to step down as chairman of the biochemistry department". Wisconsin State Journal (Madison.com). Retrieved 7 November 2011. 
  6. ^ "Management team". Deltanoid Pharmaceuticals. Retrieved 7 November 2011.  (official site)